Village Farms International Earnings Call Transcripts
Fiscal Year 2025
-
Record 2025 results featured 70% global cannabis sales growth, strong profitability, and robust cash flow, driven by Canadian and Netherlands operations. Ongoing capacity expansions and a solid balance sheet position the business for continued growth in 2026.
-
Record Q3 results with 21% sales growth, record profitability, and strong cash flow driven by Canadian and international cannabis operations. Major capacity expansions in Canada and the Netherlands are underway, supporting a positive outlook for 2026 and beyond.
-
Record Q2 profitability driven by international cannabis sales, improved margins, and strategic asset privatization. Expansion in the Netherlands and Canada is underway, with strong cash flow and a robust balance sheet supporting future growth.
-
The meeting was conducted virtually, with a quorum established and all director nominees elected. Motions on executive compensation and auditor reappointment were approved, and final voting results will be published in regulatory filings.
-
A major joint venture will spin off most produce operations, unlocking $40M in cash and focusing growth on cannabis, which saw strong international sales and margin expansion. Canadian cannabis gross margin rose to 36%, and the Netherlands segment is set for major capacity growth.
Fiscal Year 2024
-
Q4 and full year 2024 delivered strong revenue and EBITDA growth, led by Canadian cannabis and international expansion, despite a significant inventory write-down. The company expects to triple international medicinal exports in 2025 and is expanding production in the Netherlands.
-
Q3 2024 delivered strong growth in both fresh produce and Canadian cannabis, with international medical sales doubling year-over-year. The company is prioritizing high-margin sales and European expansion, especially in the Netherlands, while maintaining a strong financial position.
-
Record Q2 sales were driven by Canadian cannabis and fresh produce, with strong market share gains and positive cash flow from operations. Net loss was impacted by a non-cash impairment and produce pricing, but outlook for H2 2024 is positive, especially for produce and international cannabis.
-
The meeting confirmed a quorum and approved all motions, including the election of eight directors, executive compensation, and auditor reappointment. All director nominees were elected, and final voting results will be published in regulatory filings.